홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Perindopril → 3-[(5-Oxido-4-(phenylsulphonyl)-1,2,5-oxadiazol-3-yl)-oxy]-propionic Acid (2S,3aS,7aS)-1-[(2S)-2-{[(1S)-1-(ethoxycarbonyl)-butyl]-amino}-propionyl]-octahydro-1H-indole-2-carboxylic Acid

HRID 1013436
인쇄

반응식

HRID 1013436 반응식
[CH3:1][CH2:2][CH2:3][C@H:4]([NH:10][C@H:11]([C:13]([N:15]1[C@H:23]([C:24]([OH:26])=[O:25])[CH2:22][C@H:21]2[C@@H:16]1[CH2:17][CH2:18][CH2:19][CH2:20]2)=[O:14])[CH3:12])[C:5]([O:7][CH2:8][CH3:9])=[O:6].[O-:27][N+:28]1[O:32][N:31]=[C:30]([O:33][CH2:34][CH2:35][C:36]([OH:38])=[O:37])[C:29]=1[S:39]([C:42]1[CH:47]=[CH:46][CH:45]=[CH:44][CH:43]=1)(=[O:41])=[O:40]>>[O-:27][N+:28]1[O:32][N:31]=[C:30]([O:33][CH2:34][CH2:35][C:36]([OH:38])=[O:37])[C:29]=1[S:39]([C:42]1[CH:47]=[CH:46][CH:45]=[CH:44][CH:43]=1)(=[O:40])=[O:41].[CH2:8]([O:7][C:5]([C@@H:4]([NH:10][C@@H:11]([CH3:12])[C:13]([N:15]1[C@@H:16]2[C@@H:21]([CH2:20][CH2:19][CH2:18][CH2:17]2)[CH2:22][C@H:23]1[C:24]([OH:26])=[O:25])=[O:14])[CH2:3][CH2:2][CH3:1])=[O:6])[CH3:9]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 107807PerindoprilHCID 576261723-[[4-(Benzenesulfonyl)-5-oxido-1,2,5-oxadiazol-5-ium-3-yl]oxy]propanoic acid

생성물 1

HCID 673181673-[(5-Oxido-4-(phenylsulphonyl)-1,2,5-oxadiazol-3-yl)-oxy]-propionic Acid (2S,3aS,7aS)-1-[(2S)-2-{[(1S)-1-(ethoxycarbonyl)-butyl]-amino}-propionyl]-octahydro-1H-indole-2-carboxylic Acid

실험 절차

The compound is obtained according to the procedure described in Step E of Example 1, starting from perindopril and the compound obtained in Step B of Example 1.

후처리

  1. customThe compound is obtained

출처 및 근거

ORD 기록
ord-fa3e6970647b47f08448aa92d73e679b
출처 데이터셋
uspto-grants-2011_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07981920B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트